Analysis of a local HIV-1 epidemic in portugal highlights established transmission of Non-B and Non-G subtypes

Journal of Clinical Microbiology

Volumn 53, Issue 5, 2015, Pages 1506-1514

  Carvalho, Alexandre ^a,b,c   Costa, Patrício ^a,b   Triunfante, Vera ^a,b   Branca, Fernando ^c   Rodrigues, Fernando ^a,b   Santos, Catarina L ^a,b   Correia Neves, Margarida ^a,b   Saraiva, Margarida ^a,b   Lecour, Henrique ^d   Castro, António G ^a,b   Pedrosa, Jorge ^a,b   Osório, Nuno S ^a,b  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c HOSPITAL DE BRAGA   (Portugal)

^d CBQF CENTRO DE BIOTECNOLOGIA E QUÍMICA FINA LABORATÓRIO ASSOCIADO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; EPIDEMIC; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE A1; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE B; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE C; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE F1; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE G; INCIDENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PHYLOGEOGRAPHY; PORTUGAL; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPECIES DIVERSITY; VERY ELDERLY; VIRUS ISOLATION; VIRUS TRANSMISSION; ADOLESCENT; CLASSIFICATION; COHORT ANALYSIS; DNA SEQUENCE; GENETIC VARIATION; GENETICS; GENOTYPE; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; MIDDLE AGED; PREVALENCE; TRANSMISSION; VIROLOGY; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; EPIDEMICS; FEMALE; GENETIC VARIATION; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; PORTUGAL; PREVALENCE; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84928032043     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03611-14     Document Type: Article

References (48)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2013. Global report: UNAIDS report on the global AIDS epidemic 2013. Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland. http://ww w.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/e pidemiology/2013/gr2013/UNAIDS-Global-Report-2013-en.pdf.
2. Hemelaar J, Gouws E, Ghys PD, Osmanov S. 2006. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 20:W13-W23. http://dx.doi.org/10.1097/01.aids.0000247564.73009.bc.
3. Morison L, Buve A, Zekeng L, Heyndrickx L, Anagonou S, Musonda R, Kahindo M, Weiss HA, Hayes RJ, Laga M, Janssens W, van der Groen G, Study Group on Heterogeneity of HIV Epidemics in African Cities. 2001. HIV-1 subtypes and the HIV epidemics in four cities in sub-Saharan Africa. AIDS 15:S109-S116. http://dx.doi.org/10.1097/00002030-200108 004-00012.
4. Hudgens MG, Longini IM, Jr, Vanichseni S, Hu DJ, Kitayaporn D, Mock PA, Halloran ME, Satten GA, Choopanya K, Mastro TD. 2002. Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand. Am J Epidemiol 155:159-168. http://dx.doi.org/10.1093/aje/155.2.159.
5. Bobkov AF, Kazennova EV, Sukhanova AL, Bobkova MR, Pokrovsky VV, Zeman VV, Kovtunenko NG, Erasilova IB. 2004. An HIV type 1 subtype A outbreak among injecting drug users in Kazakhstan. AIDS Res Hum Retroviruses 20:1134-1136. http://dx.doi.org/10.1089/aid.2004.20 .1134.
6. Kiwanuka N, Laeyendecker O, Quinn TC, Wawer MJ, Shepherd J, Robb M, Kigozi G, Kagaayi J, Serwadda D, Makumbi FE, Reynolds SJ, Gray RH. 2009. HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda. AIDS 23:2479. http://dx.doi.org/10.1097/QAD.0b013e328330cc08.
7. Atlas A, Granath F, Lindström A, Lidman K, Lindbäck S, Alaeus A. 2005. Impact of HIV type 1 genetic subtype on the outcome of antiretroviral therapy. AIDS Res Hum Retroviruses 21:221-227. http://dx.doi.org/10.1089/aid.2005.21.221.
8. Keller M, Lu Y, Lalonde RG, Klein MB. 2009. Impact of HIV-1 viral subtype on CD4+ T-cell decline and clinical outcomes in antiretroviral naive patients receiving universal healthcare. AIDS 23:731-737. http://dx .doi.org/10.1097/QAD.0b013e328326f77f.
9. Easterbrook PJ, Smith M, Mullen J, O'Shea S, Chrystie I, de Ruiter A, Tatt ID, Geretti AM, Zuckerman M. 2010. Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy. J Int AIDS Soc 13:4. http://dx.doi.org/10.1186/1758-2652-13-4.
10. Santos AF, Soares MA. 2010. HIV genetic diversity and drug resistance. Viruses 2:503-531. http://dx.doi.org/10.3390/v2020503.
11. Theys K, Vercauteren J, Snoeck J, Zazzi M, Camacho RJ, Torti C, Schülter E, Clotet B, Sönnerborg A, De Luca A, Grossman Z, Struck D, Vandamme AM, Abecasis AB. 2013. HIV-1 subtype is an independent predictor of reverse transcriptase mutation K65R in HIV-1 patients treated with combination antiretroviral therapy including tenofovir. Antimicrob Agents Chemother 57:1053-1056. http://dx.doi.org/10.1128/AAC.01668-12.
12. Descamps D, Chaix M-L, André P, Brodard V, Cottalorda J, Deveau C, Harzic M, Ingrand D, Izopet J, Kohli E, Masquelier B, Mouajjah S, Palmer P, Pellegrin I, Plantier JC, Poggi C, Rogez S, Ruffault A, Schneider V, Signori-Schmück A, Tamalet C, Wirden M, Rouzioux C, Brun-Vezinet F, Meyer L, Costagliola D. 2005. French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002. J Acquir Immune Defic Syndr 38:545-552. http://dx.doi.org/10 .1097/01.qai.0000155201.51232.2e.
13. Martinez-Picado J, Gutiérrez C, de Mendoza C, Erkicia I, Domingo P, Camino X. 2005. Surveillance of drug resistance and HIV subtypes in newly diagnosed patients in Spain during 2004. Antivir Ther 10:S137.
14. Monno L, Brindicci G, Lo Caputo S, Punzi G, Scarabaggio T, Riva C, Di Bari C, Pierotti P, Saracino A, Lagioia A, Mazzotta F, Balotta C, Angarano G. 2005. HIV-1 subtypes and circulating recombinant forms (CRFs) from HIV-infected patients residing in two regions of central and southern Italy. J Med Virol 75:483-490. http://dx.doi.org/10.1002/jmv .20300.
15. Snoeck J, Van Laethem K, Hermans P, Van Wijngaerden E, Derdelinckx I, Schrooten Y, van de Vijver DA, De Wit S, Clumeck N, Vandamme A-M. 2004. Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001. J Acquir Immune Defic Syndr 35:279-285. http://dx .doi.org/10.1097/00126334-200403010-00009.
16. Chaix M-L, Seng R, Frange P, Tran L, Avettand-Fenoël V, Ghosn J, Reynes J, Yazdanpanah Y, Raffi F, Goujard C, Rouzioux C, Meyer L, ANRS PRIMO Cohort Study Group. 2013. Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy. Clin Infect Dis 56:880-887. http://dx.doi.org/10.1093/cid/cis999.
17. Ciccozzi M, Santoro MM, Giovanetti M, Andrissi L, Bertoli A, Ciotti M. 2012. HIV-1 non-B subtypes in Italy: a growing trend. New Microbiol 35:377-386.
18. Esteves A, Parreira R, Venenno T, Franco M, Piedade J, Germano de Sousa J, Canas-Ferreira WF. 2002. Molecular epidemiology of HIV type 1 infection in Portugal: high prevalence of non-B subtypes. AIDS Res Hum Retroviruses 18:313-325. http://dx.doi.org/10.1089/088922202753519089.
19. Esteves A, Parreira R, Piedade J, Venenno T, Franco M, Germano de Sousa J, Patrício L, Brum P, Costa A, Canas-Ferreira WF. 2003. Spreading of HIV-1 subtypeGand envB/gagG recombinant strains among injecting drug users in Lisbon, Portugal. AIDS Res Hum Retroviruses 19:511-517. http://dx.doi.org/10.1089/088922203766774568.
20. Freitas FB, Esteves A, Piedade J, Parreira R. 2013. Novel multiregion hybridization assay for the identification of the most prevalent genetic forms of the human immunodeficiency virus type 1 circulating in Portugal. AIDS Res Hum Retroviruses 29:318-328. http://dx.doi.org/10.1089/AID.2012.0025.
21. Abecasis AB, Martins A, Costa I, Carvalho AP, Diogo I, Gomes P, Camacho RJ, Portuguese HIV-1 Resistance Study Group. 2011. Molecular epidemiological analysis of paired pol/env sequences from Portuguese HIV type 1 patients. AIDS Res Hum Retroviruses 27:803-805. http://dx .doi.org/10.1089/aid.2010.0312.
22. Parreira R, Pádua E, Piedade J, Venenno T, Paixão MT, Esteves A. 2005. Genetic analysis of human immunodeficiency virus type 1 nef in Portugal: subtyping, identification of mosaic genes, and amino acid sequence variability. J Med Virol 77:8-16. http://dx.doi.org/10.1002/jmv.20408.
23. Palma AC, Araújo F, Duque V, Borges F, Paixão MT, Camacho R, Portuguese SPREAD Network. 2007. Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal. Infect Genet Evol 7:391-398. http://dx.doi.org/10 .1016/j.meegid.2007.01.009.
24. Delgado E, Thomson MM, Villahermosa ML, Sierra M, Ocampo A, Miralles C, Rodríguez-Pérez R, Diz-Aren J, Ojea-de Castro R, Losada E, Cuevas MT, Vazquez-de-Parga E, Carmona R, Perez-Alvarez L, Medrano L, Cuevas L, Taboada JA, Najera R. 2002. Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure. J Acquir Immune Defic Syndr 29:536-543. http://dx.doi.org/10.1097/00126334-200204150-00016.
25. Bártolo I, Abecasis AB, Borrego P, Barroso H, McCutchan F, Gomes P, Camacho R, Taveira N. 2011. Origin and epidemiological history of HIV-1 CRF14-BG. PLoS One 6:e24130. http://dx.doi.org/10.1371/journal.pone.0024130.
26. Paraskevis D, Nikolopoulos G, Tsiara C, Paraskeva D, Antoniadou A, Lazanas M, Gargalianos P, Psychogiou M, Malliori M, Kremastinou J, Hatzakis A. 2011. HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. Euro Surveill 16:pii-19962. http://www .eurosurveillance.org/ViewArticle.aspx?ArticleId-19962.
27. Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM. 2008. The challenge of HIV-1 subtype diversity. N Engl J Med 358:1590-1602. http://dx.doi.org/10.1056/NEJMra0706737.
28. Instituto Nacional de Saúde Doutor Ricardo Jorge (INSA). 2012. Infeção VIH/SIDA: a situação em Portugal a 31 de Dezembro de 2011. Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal. http://repositorio.insa.pt/bitstream/10400.18/984/3/relatorio%20VIH %20SIDA%202011%20versao%20web.pdf.
29. Hué S, Clewley JP, Cane PA, Pillay D. 2004. HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy. AIDS 18:719-728. http://dx.doi.org/10.1097/00002030-200403260-00002.
30. Brenner BG, Roger M, Routy J-P, Moisi D, Ntemgwa M, Matte C, Baril J-G, Thomas R, Rouleau D, Bruneau J, Leblanc R, Legault M, Tremblay C, Charest H, Wainberg MA, Quebec Primary HIV Infection Study Group. 2007. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 195:951-959. http://dx.doi.org/10.1086/512088.
31. Lewis F, Hughes GJ, Rambaut A, Pozniak A, Brown AJL. 2008. Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med 5:e50. http://dx.doi.org/10.1371/journal.pmed.0050050.
32. Pineda-Peña A-C, Faria NR, Imbrechts S, Libin P, Abecasis AB, Deforche K, Gómez-López A, Camacho RJ, de Oliveira T, Vandamme A-M. 2013. Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools. Infect Genet Evol 19:337-348. http://dx.doi .org/10.1016/j.meegid.2013.04.032.
33. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, Ingersoll R, Sheppard HW, Ray SC. 1999. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73:152-160.
34. Martin D, Rybicki E. 2000. RDP: detection of recombination amongst aligned sequences. Bioinformatics 16:562-563. http://dx.doi.org/10.1093/bioinformatics/16.6.562.
35. Edgar RC. 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32:1792-1797. http://dx.doi .org/10.1093/nar/gkh340.
36. Stamatakis A. 2014. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30:1312-1313. http://dx.doi.org/10.1093/bioinformatics/btu033.
37. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O. 2010. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 59:307-321. http://dx.doi.org/10.1093/sysbio/syq010.
38. Drummond AJ, Rambaut A. 2007. BEAST: Bayesian Evolutionary Analysis by Sampling Trees. BMC Evol Biol 7:214. http://dx.doi.org/10.1186/1471-2148-7-214.
39. Darriba D, Taboada GL, Doallo R, Posada D. 2012. jModelTest 2: more models, new heuristics and parallel computing. Nat Methods 9:772-772. http://dx.doi.org/10.1038/nmeth.2109.
40. Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, Heneine W, Kantor R, Jordan MR, Schapiro JM, Vandamme AM, Sandstrom P, Boucher CA, van de Vijver D, Rhee SY, Liu TF, Pillay D, Shafer RW. 2009. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One 4:e4724. http://dx.doi .org/10.1371/journal.pone.0004724.
41. Kaye M, Chibo D, Birch C. 2008. Phylogenetic investigation of transmission pathways of drug-resistant HIV-1 utilizing pol sequences derived from resistance genotyping. J Acquir Immune Defic Syndr 49:9-16. http://dx.doi.org/10.1097/QAI.0b013e318180c8af.
42. Chalmet K, Staelens D, Blot S, Dinakis S, Pelgrom J, Plum J, Vogelaers D, Vandekerckhove L, Verhofstede C. 2010. Epidemiological study of phylogenetic transmission clusters in a local HIV-1 epidemic reveals distinct differences between subtype B and non-B infections. BMC Infect Dis 10:262. http://dx.doi.org/10.1186/1471-2334-10-262.
43. Torti C, Lapadula G, Izzo I, Brindicci G, Labbate G, Quiros-Roldan E, Diallo I, Gargiulo F, Castelnuovo F, Calabresi A, Carosi G, Manca N, Monno L. 2010. Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications. Epidemiol Infect 138:1298-1307. http://dx.doi.org/10.1017/S0950268810000166.
44. von Wyl V, Kouyos RD, Yerly S, Böni J, Shah C, Bürgisser P, Klimkait T, Weber R, Hirschel B, Cavassini M, Staehelin C, Battegay M, Vernazza PL, Bernasconi E, Ledergerber B, Bonhoeffer S, Gunthard HF, Swiss HIV Cohort Study. 2011. The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland. J Infect Dis 204:1095-1103. http://dx.doi.org/10.1093/infdis/jir491.
45. Holguin A, de Mulder M, Yebra G, Lopez M, Soriano V. 2008. Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain. Curr HIV Res 6:327-334. http://dx.doi.org/10.2174/157016208785132455.
46. Vermund SH, Leigh-Brown AJ. 2012. The HIV epidemic: high-income countries. Cold Spring Harb Perspect Med 2:a007195. http://dx.doi.org/10.1101/cshperspect.a007195.
47. Bender GJ, Yoder PS. 1974. Whites in Angola on the eve of independence: the politics of numbers. Africa Today 23-37.
48. Bártolo I, Rocha C, Bartolomeu J, Gama A, Marcelino R, Fonseca M, Mendes A, Epalanga M, Silva PC, Taveira N. 2009. Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic. Infect Genet Evol 9:672-682. http://dx.doi.org/10.1016/j.meegid.2008.05.003.